$4.90-0.45 (-8.41%)
Quantum X Labs Inc., through its subsidiaries, focuses on quantum technology, digital advertising and computing, and enterprise artificial intelligence (AI) solutions.
Quantum X Labs Inc. in the Technology sector is trading at $4.90 with a market capitalization of $62M. The stock is currently 36% below its 52-week high of $7.70, remaining 73.8% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $353,000β | -$6.16Mβ | $2.72Mβ | $2.28Mβ | $529,000 |
| Gross Profit | $221,000β | -$123,000β | $584,000β | $401,000β | $395,000 |
| Operating Income | -$550,000β | $1.81Mβ | -$1.26Mβ | -$1.77Mβ | -$55,000 |
| Net Income | -$605,000β | -$566,000β | -$3.39Mβ | -$11.66Mβ | -$3.67M |
Quantum X Labs Inc., through its subsidiaries, focuses on quantum technology, digital advertising and computing, and enterprise artificial intelligence (AI) solutions. The company develops and owns quantum computing technology as well as a quantum er...
In a significant development for the AI chip sector, Arteris, Inc. has announced an expanded partnership with Arm to enhance semiconductor cybersecurity. This alliance builds on a five-year collaboration, utilizing Arteris' Cycuity Radix hardware security assurance product. By integrating Cycuity Radix into Arm's CPU design processes, the partnership aims to proactively address potential security vulnerabilities and strengthen the security assurance of processor cores. This strategic move...
Tel-Aviv, Israel, July 14, 2026 (GLOBE NEWSWIRE) -- Quantum X Labs Inc. (the "Company") (NASDAQ: QXL) today announced that the CliniQuantum operation, has successfully validated a quantum sampling workflow that enables continuous probability distributions to be represented and analyzed within a quantum computing framework using Quantum X Labs' proprietary algorithmic technology and related intellectual property portfolio. The milestone demonstrates the ability to transform continuous data into quantum-compatible energy map representations capable of supporting advanced quantum algorithms.
The company makes its money from intellectual property, so why did investors balk when it decided to defend it in court.
Quantum X Labs Ltd. (Nasdaq: QXL) today announced the appointment of Dr. Ira Wolfson to its leadership team as a quantum researcher, strengthening the Company's scientific and engineering capabilities as it advances the development of next-generation quantum technologies across computing, sensing, and enabling quantum systems. Dr. Wolfson brings decades of multidisciplinary experience spanning advanced physics, complex systems engineering, applied research, and the translation of breakthrough technologies into practical solutions.
Discover why Zacks issues an "Underperform" rating for QXL, being the first on Wall Street to initiate coverage on the stock. Learn why liquidity concerns, persistent losses, funding dependence and a weakening legacy business overshadow the company's promising quantum computing ambitions.